BVF Partners L P/il, 10% Owner at Xenon Pharmaceuticals Inc. (XENE), bought 38,187 shares at $3.84 ($147K) on 2017-06-15, disclosed to the SEC on 2017-06-19.
Open-market purchase of $147k XENE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.84 | 1,160 | $4K | 3.0% |
| 2 | $3.84 | 3,845 | $15K | 10.1% |
| 3 | $3.84 | 6,774 | $26K | 17.7% |
| 4 | $3.84 | 1,160 | $4K | 3.0% |
| 5 | $3.84 | 3,845 | $15K | 10.1% |
| 6 | $3.84 | 6,774 |
| $26K |
| 17.7% |
| 7 | $3.85 | 1,064 | $4K | 2.8% |
| 8 | $3.85 | 3,873 | $15K | 10.2% |
| 9 | $3.85 | 6,097 | $23K | 16.0% |
| 10 | $3.85 | 357 | $1K | 0.9% |
| 11 | $3.85 | 1,271 | $5K | 3.3% |
| 12 | $3.85 | 1,967 | $8K | 5.2% |
| Total | $3.84 avg | 38,187 | $147K | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |